. A Phase 2 Clinical Trial of Pf-05212377 (Sam-760) in Subjects With Mild to Moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Volume 12, Issue 7,


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:


  1. PF-05212377